7Bates D W,Cullen D,Laird N,et al. Incidence of adverse drug events and potential adverse drug events[ J ]. JAMA, 1995,274:29. 被引量:1
8Paoletti R D, Casey E W. Reducing costs through centralization and standardization of i. v. admixture program [ J ]. Am J Health Syst Pharm,2000,57 (12) :1147. 被引量:1